Transcriptomics

Dataset Information

0

Functional genomics identify distinct and overlapping genes mediating resistance to different classes of heterobifunctional degraders of oncoproteins


ABSTRACT: Heterobifunctional proteolysis-targeting chimeric compounds leverage the activity of E3 ligases to induce degradation of target oncoproteins and exhibit potent preclinical antitumor activity. To dissect the mechanisms regulating tumor cell sensitivity to different classes of pharmacological "degraders" of oncoproteins, we performed genome-scale CRISPR/Cas9-based gene-editing studies. We observed that myeloma cell resistance to "degraders" of different targets (BET bromodomain proteins, CDK9) and operating through CRBN (degronimids) or VHL is primarily mediated by prevention of, rather than adaptation to, breakdown of the target oncoprotein; involves loss-of-function for the cognate E3 ligase or interactors/regulators of the respective cullin-RING ligase (CRL) complex. The substantial gene-level differences for CRBN- vs. VHL-based degraders explains mechanistically the lack of cross-resistance for degraders targeting the same protein via different E3 ligase/CRLs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE162205 | GEO | 2021/02/12

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-01-20 | GSE108763 | GEO
2021-07-30 | PXD022060 | Pride
2021-07-30 | PXD022058 | Pride
2021-07-30 | PXD022022 | Pride
2021-07-30 | PXD022021 | Pride
2021-07-30 | PXD022059 | Pride
2022-10-13 | PXD022399 | Pride
2022-06-20 | PXD032239 | Pride
2024-03-20 | PXD047455 | Pride
2024-03-20 | PXD042691 | Pride